1. Zhang, Yan, Wang, He, Zhu, Guochun, Qian, Airong, Chen, Wei. 2020. F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways. In International journal of biological sciences, 16, 1629-1639. doi:10.7150/ijbs.41867. https://pubmed.ncbi.nlm.nih.gov/32226307/
2. Platé, Manuela, Lawson, Phillippa J, Hill, Michael R, Hurst, John R, Chambers, Rachel C. 2015. Role of a functional polymorphism in the F2R gene promoter in sarcoidosis. In Respirology (Carlton, Vic.), 20, 1285-7. doi:10.1111/resp.12608. https://pubmed.ncbi.nlm.nih.gov/26278396/
3. Wu, Xingwei, Wang, Shengnan, Wang, Chenci, Wu, Chengwei, Zhao, Zhiyong. 2024. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma. In Scientific reports, 14, 2468. doi:10.1038/s41598-024-52397-6. https://pubmed.ncbi.nlm.nih.gov/38291086/
4. Pan, Yuesong, Wangqin, Runqi, Li, Hao, Wang, David, Wang, Yongjun. 2020. F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA. In Neurology, 96, e1-e9. doi:10.1212/WNL.0000000000011078. https://pubmed.ncbi.nlm.nih.gov/33093222/
5. Gigante, Bruna, Vikström, Max, Meuzelaar, Linda Strömqvist, Hamsten, Anders, de Faire, Ulf. . Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels. In Thrombosis and haemostasis, 101, 943-53. doi:. https://pubmed.ncbi.nlm.nih.gov/19404549/
6. Dong, Yan-Ming, Bao, Guo-Qiang. 2024. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management. In Open life sciences, 19, 20221001. doi:10.1515/biol-2022-1001. https://pubmed.ncbi.nlm.nih.gov/39655193/
智鼠故事 
